The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Association Between a Literature-Based Genetic Risk Score and Cardiovascular Events in Women
Open accessAbstract
CONTEXT: While multiple genetic markers associated with cardiovascular disease have been identified by genome-wide association studies, their aggregate effect on risk beyond traditional factors is uncertain, particularly among women. OBJECTIVE: To test the predictive ability of a literature-based genetic risk score for cardiovascular disease. DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort of 19,313 initially healthy white women in the Women's Genome Health Study followed up over a median of 12.3 years (interquartile range, 11.6-12.8 years). Genetic risk scores were constructed from the National Human Genome Research Institute's catalog of genome-wide association study results published between 2005 and June 2009. MAIN OUTCOME MEASURE: Incident myocardial infarction, stroke, arterial revascularization, and cardiovascular death. RESULTS: A total of 101 single nucleotide polymorphisms reported to be associated with cardiovascular disease or at least 1 intermediate cardiovascular disease phenotype at a published P value of less than 10(-7) were identified and risk alleles were added to create a genetic risk score. During follow-up, 777 cardiovascular disease events occurred (199 myocardial infarctions, 203 strokes, 63 cardiovascular deaths, 312 revascularizations). After adjustment for age, the genetic risk score had a hazard ratio (HR) for cardiovascular disease of 1.02 per risk allele (95% confidence interval [CI], 1.00-1.03/risk allele; P = .006). This corresponds to an absolute cardiovascular disease risk of 3% over 10 years in the lowest tertile of genetic risk (73-99 risk alleles) and 3.7% in the highest tertile (106-125 risk alleles). However, after adjustment for traditional factors, the genetic risk score did not improve discrimination or reclassification (change in c index from Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults [ATP III] risk score, 0; net reclassification improvement, 0.5%; [P = .24]). The genetic risk score was not associated with cardiovascular disease risk (ATP III-adjusted HR/allele, 1.00; 95% CI, 0.99-1.01). In contrast, self-reported family history remained significantly associated with cardiovascular disease in multivariable models. CONCLUSION: After adjustment for traditional cardiovascular risk factors, a genetic risk score comprising 101 single nucleotide polymorphisms was not significantly associated with the incidence of total cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“models to combine multiple markers into a cumulative risk score are often flawed and are usually no better than traditional risk factors such as family history, demographics and non-genetic clinical phenotypes.”
From Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (2015) · cites this paper as [56]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Our finding that a polygenic risk score has robust associations with incident coronary events is well aligned with previous studies of both primary and secondary prevention populations.16–24”
From Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease (2016) · cites this paper as [18]
Experimental — accuracy not yet measuredIn the citing paper
“In some conditions the process of genetic counselling can be optimized and extended with cascade screening, which identifies patients at risk and enables timely treatment of affected relatives, as is the case for familial hypercholesterolaemia.72,75”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [72]
In the citing paper
“These risk alleles, when aggregated into a polygenic risk score, are predictive of incident coronary events and provide a continuous and quantitative measure of genetic susceptibility.16–24”
From Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease (2016) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
A second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
Cited by
Sorted by citations
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Self-citationHeart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149
Self-citationProgress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,865
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
Khera, A. V., Emdin, C. A., Drake, I., Natarajan, P., Bick, A. G., Cook, N. R., Chasman, D. I., Baber, U., Mehran, R., Rader, D. J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1605086 · Cited by 1,460
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,435
Mechanisms of Age-Related Macular Degeneration
Ambati, J., & Fowler, B. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.018 · Cited by 1,062
Genetic Heterogeneity in Human Disease
McClellan, J., & King, M.-C. (2010) · Cell · doi:10.1016/j.cell.2010.03.032 · Cited by 981
Ference, B. A., Yoo, W., Alesh, I., Mahajan, N., Mirowska, K. K., Mewada, A., Kahn, J., Afonso, L., Williams, K. A., & Flack, J. M. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.017 · Cited by 898
Role of Inactivity in Chronic Diseases: Evolutionary Insight and Pathophysiological Mechanisms
Booth, F. W., Roberts, C. K., Thyfault, J. P., Ruegsegger, G. N., & Toedebusch, R. G. (2017) · Physiological Reviews · doi:10.1152/physrev.00019.2016 · Cited by 696
Pitfalls of predicting complex traits from SNPs
Wray, N. R., Yang, J., Hayes, B. J., Price, A. L., Goddard, M. E., & Visscher, P. M. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3457 · Cited by 690
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Perk, J., Backer, G. D., Gohlke, H., Graham, I. M., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cífková, R., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.007 · Cited by 702
Leening, M. J. G., Vedder, M. M., Witteman, J. C. M., Pencina, M. J., & Steyerberg, E. W. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1522 · Cited by 594
Ripatti, S., Tikkanen, E., Orho-Melander, M., Havulinna, A. S., Silander, K., Sharma, A., Guiducci, C., Perola, M., Jula, A., Sinisalo, J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61267-6 · Cited by 562
Elliott, J., Bodinier, B., Bond, T. A., Chadeau‐Hyam, M., Εvangelou, Ε., Moons, K. G. M., Dehghan, A., Muller, D. C., Elliott, P., & Tzoulaki, I. (2020) · JAMA · doi:10.1001/jama.2019.22241 · Cited by 472
Genetic signatures of exceptional longevity in humans
Sebastiani, P., Solovieff, N., DeWan, A. T., Walsh, K. M., Puca, A., Hartley, S. W., Melista, E., Andersen, S., Dworkis, D. A., Wilk, J. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029848 · Cited by 464
Identification of IL6R and chromosome 11q13.5 as risk loci for asthma
Ferreira, M. A., Matheson, M. C., Duffy, D. L., Marks, G. B., Hui, J., Le Souëf, P., Danoy, P., Baltic, S., Nyholt, D. R., Jenkins, M., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60874-x · Cited by 381
Ganz, P., Heidecker, B., Hveem, K., Jonasson, C., Kato, S., Segal, M. R., Sterling, D. G., & Williams, S. A. (2016) · JAMA · doi:10.1001/jama.2016.5951 · Cited by 364
Genomic prediction of coronary heart disease
Abraham, G., Havulinna, A. S., Bhalala, O. G., Byars, S. G., De Livera, A. M., Yetukuri, L., Tikkanen, E., Perola, M., Schunkert, H., Sijbrands, E. J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw450 · Cited by 338
Atherosclerotic Plaque Destabilization
Silvestre-Roig, C., de Winther, M. P. J., Weber, C., Daemen, M. J. A. P., Lutgens, E., & Soehnlein, O. (2014) · Circulation Research · doi:10.1161/circresaha.114.302355 · Cited by 346
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)
Perk, J., Backer, G. D., Gohlke, H., Graham, I. M., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cífková, R., et al. (2012) · International Journal of Behavioral Medicine · doi:10.1007/s12529-012-9242-5 · Cited by 319
Kullo, I. J., Jouni, H., Austin, E. E., Brown, S.-A., Kruisselbrink, T. M., Isseh, I. N., Haddad, R. A., Marroush, T. S., Shameer, K., Olson, J. E., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.020109 · Cited by 267
Beyond Missing Heritability: Prediction of Complex Traits
Makowsky, R., Pajewski, N. M., Klimentidis, Y. C., Vazquez, A. I., Duarte, C. W., Allison, D. B., & Campos, G. D. L. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002051 · Cited by 260
Worldwide Exposures to Cardiovascular Risk Factors and Associated Health Effects
Tzoulaki, I., Elliott, P., Kontis, V., & Ezzati, M. (2016) · Circulation · doi:10.1161/circulationaha.115.008718 · Cited by 245
Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, G. D. B. (. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312450228 · Cited by 863
Genetics of coronary artery disease and myocardial infarction
Dai, X. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i1.1 · Cited by 230
Thanassoulis, G., Peloso, G. M., Pencina, M. J., Hoffmann, U., Fox, C. S., Cupples, L. A., Levy, D., D'Agostino, R. B., Hwang, S.-J., & O'Donnell, C. J. (2012) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.111.961342 · Cited by 211
Genetic Risk Prediction and a 2-Stage Risk Screening Strategy for Coronary Heart Disease
Tikkanen, E., Havulinna, A. S., Palotie, A., Salomaa, V., & Ripatti, S. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.301120 · Cited by 175
Biomarkers for the Prediction of Type 2 Diabetes and Cardiovascular Disease
Herder, C., Karakas, M., & Köenig, W. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.93 · Cited by 168
Elosúa, R., Sayols-Baixeras, S., Lluís-Ganella, C., & Lucas, G. (2014) · The Application of Clinical Genetics · doi:10.2147/tacg.s35301 · Cited by 169
Multilocus Genetic Risk Scores for Coronary Heart Disease Prediction
Ganna, A., Magnusson, P. K. E., Pedersen, N. L., de Faire, U., Reilly, M., Ärnlöv, J., Sundström, J., Hamsten, A., & Ingelsson, E. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.301218 · Cited by 156
Multiple SNP testing improves risk prediction of first venous thrombosis
de Haan, H. G., Bezemer, I. D., Doggen, C. J. M., le Cessie, S., Reitsma, P. H., Arellano, A. R., Tong, C. H., Devlin, J. J., Bare, L. A., Rosendaal, F. R., et al. (2012) · Blood · doi:10.1182/blood-2011-12-397752 · Cited by 158
Beekman, M., Nederstigt, C., Suchiman, H. E. D., Kremer, D., van der Breggen, R., Lakenberg, N., Alemayehu, W. G., de Craen, A. J. M., Westendorp, R. G. J., Boomsma, D. I., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003540107 · Cited by 153
Childhood Physical, Environmental, and Genetic Predictors of Adult Hypertension
Juhola, J., Oikonen, M., Magnussen, C. G., Mikkilä, V., Siitonen, N., Jokinen, E., Laitinen, T. T., Würtz, P., Gidding, S. S., Taittonen, L. M., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.085977 · Cited by 152
Opportunities and Challenges Associated with Clinical Diagnostic Genome Sequencing
Schrijver, I., Aziz, N., Farkas, D. H., Furtado, M. R., Gonzalez, A. F., Greiner, T. C., Grody, W. W., Hambuch, T. M., Kalman, L. V., Kant, J. A., et al. (2012) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.04.006 · Cited by 150
Genetic Signatures of Exceptional Longevity in Humans
Sebastiani, P., Solovieff, N., Puca, A., Hartley, S. W., Melista, E., Andersen, S., Dworkis, D. A., Wilk, J. B., Myers, R. H., Steinberg, M. H., et al. (2010) · Science · doi:10.1126/science.1190532 · Cited by 141
RetractedGoek, O.-N., Prehn, C., Sekula, P., Römisch-Margl, W., Döring, A., Gieger, C., Heier, M., Koenig, W., Wang-Sattler, R., Illig, T., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft217 · Cited by 143
The General Public’s Understanding and Perception of Direct-to-Consumer Genetic Test Results
Leighton, J. W., Valverde, K. D., & Bernhardt, B. A. (2011) · Public Health Genomics · doi:10.1159/000327159 · Cited by 142
Validity of polygenic risk scores: are we measuring what we think we are?
Janssens, A. C. J. W. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz205 · Cited by 129
Child Development and Molecular Genetics: 14 Years Later
Plomin, R. J. (2012) · Child Development · doi:10.1111/j.1467-8624.2012.01757.x · Cited by 125
Genetic Markers Enhance Coronary Risk Prediction in Men: The MORGAM Prospective Cohorts
Hughes, M., Saarela, O., Stritzke, J., Kee, F., Silander, K., Klopp, N., Kontto, J. P., Karvanen, J., Willenborg, C., Salomaa, V. V., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040922 · Cited by 120
Genomic risk prediction of complex human disease and its clinical application
Abraham, G., & Inouye, M. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.06.005 · Cited by 114
Genetic Risk Score and Risk of Myocardial Infarction in Hispanics
Qi, L., Ma, J., Qi, Q., Hartiala, J., Allayee, H., & Campos, H. (2011) · Circulation · doi:10.1161/circulationaha.110.976613 · Cited by 109
Aschard, H., Chen, J., Cornelis, M. C., Chibnik, L. B., Karlson, E. W., & Kraft, P. L. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.04.017 · Cited by 111
Practical challenges in integrating genomic data into the electronic health record
Kho, A. N., Rasmussen, L. V., Connolly, J. J., Peissig, P. L., Starren, J., Hakonarson, H., & Hayes, M. G. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.131 · Cited by 108
Davies, R. W., Dandona, S., Stewart, A. F. R., Chen, L., Ellis, S. G., Tang, W. H. W., Hazen, S. L., Roberts, R., McPherson, R., & Wells, G. A. (2010) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.946269 · Cited by 102
Ma, G. K., & Ladabaum, U. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.01.042 · Cited by 97
Ten questions about systems biology
Joyner, M. J., & Pedersen, B. K. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2010.201509 · Cited by 93
Current concepts and clinical applications of stroke genetics
Falcone, G. J., Malik, R., Dichgans, M., & Rosand, J. M. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70029-8 · Cited by 98
Genetic Cardiovascular Risk Prediction
Thanassoulis, G., & Vasan, R. S. (2010) · Circulation · doi:10.1161/circulationaha.109.909309 · Cited by 85
Validation of My Family Health Portrait for six common heritable conditions
Facio, F. M., Feero, W. G., Linn, A., Oden, N. L., Manickam, K., & Biesecker, L. G. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181e15bd5 · Cited by 84
Current Applications of Genetic Risk Scores to Cardiovascular Outcomes and Subclinical Phenotypes
Smith, J. A., Ware, E. B., Middha, P., Beacher, L., & Kardia, S. L. R. (2015) · Current Epidemiology Reports · doi:10.1007/s40471-015-0046-4 · Cited by 82
Haga, S. B., Carrig, M. M., O’Daniel, J. M., Orlando, L. A., Killeya‐Jones, L. A., Ginsburg, G. S., & Cho, A. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1651-7 · Cited by 79
Risk factors and interventions with statistically significant tiny effects
Siontis, G. C., & Ioannidis, J. P. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr099 · Cited by 80
Genomewide Association Studies in Cardiovascular Disease—An Update 2011
Zeller, T., Blankenberg, S., & Diemert, P. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.170431 · Cited by 78
Genome-wide association studies of chronic kidney disease: what have we learned?
O’Seaghdha, C. M., & Fox, C. S. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.189 · Cited by 77
Patel, S. D., Le-Niculescu, H., Koller, D. L., Green, S. D., Lahiri, D. K., McMahon, F. J., Nürnberger, J. I., & Niculescu, A. B. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31087 · Cited by 75
Genetics in Population Health Science: Strategies and Opportunities
Belsky, D. W., Moffitt, T. E., & Caspi, A. (2013) · American Journal of Public Health · doi:10.2105/ajph.2012.301139 · Cited by 75
Brautbar, A., Pompeii, L. A., Dehghan, A., Ngwa, J. S., Nambi, V., Virani, S. S., Rivadeneira, F., Uitterlinden, A. G., Hofman, A., Witteman, J. C. M., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.035 · Cited by 71
Predicting Stroke Through Genetic Risk Functions
Ibrahim‐Verbaas, C. A., Fornage, M., Bis, J. C., Choi, S. H., Psaty, B. M., Meigs, J. B., Rao, M., Nalls, M. A., Fontes, J. D., O’Donnell, C. J., et al. (2014) · Stroke · doi:10.1161/strokeaha.113.003044 · Cited by 71
Personalized medicine: hope or hype?
Salari, K., Watkins, H. C., & Ashley, E. A. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs112 · Cited by 76
Iribarren, C., Lü, M., Jorgenson, E., Martínez, M., Lluís-Ganella, C., Subirana, I., Salas, E., & Elosúa, R. (2016) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.116.001522 · Cited by 67
Görman, U., Mathers, J. C., Grimaldi, K. A., Ahlgren, J., & Nordström, K. (2013) · Genes & Nutrition · doi:10.1007/s12263-013-0338-6 · Cited by 65
Implications of discoveries from genome-wide association studies in current cardiovascular practice
Jeemon, P. (2011) · World Journal of Cardiology · doi:10.4330/wjc.v3.i7.230 · Cited by 65
Payne, R. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04219.x · Cited by 70
The genetics of coronary heart disease
Swerdlow, D. I., Holmes, M. V., Harrison, S. C., & Humphries, S. E. (2012) · British Medical Bulletin · doi:10.1093/bmb/lds009 · Cited by 64
Whole Genome Sequences of a Male and Female Supercentenarian, Ages Greater than 114 Years
Sebastiani, P., Riva, A., Montano, M. A., Pham, P., Torkamani, A., Scherba, E., Benson, G., Milton, J. N., Baldwin, C. T., Andersen, S. L., et al. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2011.00090 · Cited by 64
Classical and Novel Biomarkers for Cardiovascular Risk Prediction in the United States
Folsom, A. R. (2013) · Journal of Epidemiology · doi:10.2188/jea.je20120157 · Cited by 65
Scott, I. C., Seegobin, S., Steer, S. E., Tan, R., Forabosco, P., Hinks, A., Eyre, S., Morgan, A. W., Wilson, A. G., Hocking, L. J., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003808 · Cited by 63
9p21 and the Genetic Revolution for Coronary Artery Disease
Roberts, R., & Stewart, A. F. R. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.172759 · Cited by 64
Assessment of the value of a genetic risk score in improving the estimation of coronary risk
Lluís-Ganella, C., Subirana, I., Lucas, G., Tomás, M., Muñoz-Escudero, D., Sentı́, M., Salas, E., Sala, J., Ramos, R., Ordovás, J. M., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.03.024 · Cited by 63
Productivity Shortfalls in Drug Discovery: Contributions from the Preclinical Sciences?
Williams, M. J. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.171751 · Cited by 58
Genetics of Coronary Artery Disease and Myocardial Infarction - 2013
Kessler, T., Erdmann, J., & Schunkert, H. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0368-0 · Cited by 56
Hindieh, W., Pilote, L., Cheema, A. N., Al-Lawati, H., Labos, C., Dufresne, L., Engert, J. C., & Thanassoulis, G. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306944 · Cited by 61
The evolution of genetic-based risk scores for lipids and cardiovascular disease
Dron, J. S., & Hegele, R. A. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000576 · Cited by 59
For the investigators of the Canadian HIV and Aging Cohort Study, Durand, M., Chartrand‐Lefebvre, C., Baril, J.-G., Trottier, S., Trottier, B., Harris, M., Walmsley, S. L., Conway, B., Wong, A., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2692-2 · Cited by 54
Müller, B., Wilcke, A., Boulesteix, A., Bräuer, J., Passarge, E., Boltze, J., & Kirsten, H. (2016) · Human Genetics · doi:10.1007/s00439-016-1636-z · Cited by 54
the Utility of Genome-Wide Association Studies in Hepatology
Karlsen, T. H., Melum, E., & Franke, A. (2010) · Hepatology · doi:10.1002/hep.23564 · Cited by 56
Elliott, P., Muller, D. C., Schneider-Luftman, D., Pazoki, R., Εvangelou, Ε., Dehghan, A., Neal, B. C., & Tzoulaki, I. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14302 · Cited by 52
Lu, Y., Feskens, E. J. M., Boer, J. M. A., Imholz, S., Verschuren, W. M. M., Wijmenga, C., Vaarhorst, A. A. M., Slagboom, P. E., Müller, M. M., & Dollé, M. E. T. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.08.053 · Cited by 50
CVD screening in low-risk, asymptomatic adults: clinical trials needed
Polonsky, T. S., & Greenland, P. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.114 · Cited by 50
Giant sucking sound: can physiology fill the intellectual void left by the reductionists?
Joyner, M. J. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00565.2011 · Cited by 47
Evaluation of genetic risk score models in the presence of interaction and linkage disequilibrium
Che, R., & Motsinger‐Reif, A. A. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00138 · Cited by 50
Literature-Based Genetic Risk Scores for Coronary Heart Disease
Vaarhorst, A. A. M., Lu, Y., Heijmans, B. T., Dollé, M. E. T., Böhringer, S., Putter, H., Imholz, S., Merry, A. H. H., van Greevenbroek, M. M. J., Jukema, J. W., et al. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.960708 · Cited by 50
Risk assessment in the prevention of cardiovascular disease in low-resource settings
Ofori, S., & Odia, O. J. (2015) · Indian Heart Journal · doi:10.1016/j.ihj.2015.07.004 · Cited by 48
Patel, R. S., Sun, Y. V., Hartiala, J., Veledar, E., Su, S., Sher, S., Liu, Y. X., Rahman, A. M., Patel, R., Rab, S. T., et al. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.960229 · Cited by 46
de Vries, P. S., Kavousi, M., Ligthart, S., Uitterlinden, A. G., Hofman, A., Franco, O. H., & Dehghan, A. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv070 · Cited by 48
Okser, S., Lehtimäki, T. J., Elo, L. L., Mononen, N., Peltonen, N., Kähönen, M. A. P., Juonala, M., Fan, Y., Hernesniemi, J. A., Laitinen, T. P., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001146 · Cited by 47
Niiranen, T., & Vasan, R. S. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2016.1176528 · Cited by 49
Zannad, F. M., Backer, G. D., Graham, I. M., Lorenz, M., Mancia, G., Morrow, D. A., Reiner, Ž., Köenig, W., Dallongeville, J., MacFadyen, R. J., et al. (2012) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.01023.x · Cited by 47
Utility of genetic determinants of lipids and cardiovascular events in assessing risk
Holmes, M. V., Harrison, S., Talmud, P. J., Hingorani, A. D., & Humphries, S. E. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.6 · Cited by 44
Systematic investigation of protein–small molecule interactions
Li, X., Wang, X., & Snyder, M. P. (2012) · IUBMB Life · doi:10.1002/iub.1111 · Cited by 46
Do Polygenic Risk Scores Improve Patient Selection for Prevention of Coronary Artery Disease?
Khan, S. S., Cooper, R., & Greenland, P. (2020) · JAMA · doi:10.1001/jama.2019.21667 · Cited by 42
Precision Medicine, Cardiovascular Disease and Hunting Elephants
Joyner, M. J. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.02.004 · Cited by 47
Zhang, X., Ni, Y., Liu, Y., Zhang, L., Zhang, M., Fang, X., Yang, Z., Wang, Q., Li, H., Xia, Y., et al. (2019) · Environmental Health · doi:10.1186/s12940-019-0471-9 · Cited by 43
Khoury, M. J., Feero, W. G., & Valdez, R. A. (2010) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.03.019 · Cited by 42
Functional Genomics Applied to Cardiovascular Medicine
Cappola, T. P., & Margulies, K. B. (2011) · Circulation · doi:10.1161/circulationaha.111.027300 · Cited by 42
Ding, K., Bailey, K. R., & Kullo, I. J. (2011) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-11-66 · Cited by 40
Metadata
- Authors
- Paynter, N. P.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Paynter, Nina P.
- ORCID
- Paynter, Nina P.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-02-17
- Volume
- 303
- Issue
- 7
- Pages
- 631
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC2845522
- OpenAlex
- W2015060037
- Cited by
- 361
- References
- 42
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 5 · 2023: 3 · 2022: 8 · 2021: 5 · 2020: 9 · 2019: 6 · 2018: 10 · 2017: 22 · 2016: 22 · 2015: 26 · 2014: 32 · 2013: 45 · 2012: 74
- FWCI
- 37.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r01hl043851-10)
- National Heart, Lung, and Blood Institute (R01HL080467, HL043851, R01‐HL043851)
- National Cancer Institute (CA 047988, R01CA047988)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- polygenic risk score, cardiovascular disease, women, myocardial infarction, stroke, cardiovascular mortality, arterial revascularization, single nucleotide polymorphisms, family history, cardiovascular risk prediction, reclassification, risk discrimination, traditional cardiovascular risk factors, women's cardiovascular health
- MeSH terms
- Alleles, Cardiovascular Diseases, Female, Genetic Markers, Humans, Middle Aged, Phenotype, Prospective Studies, Risk, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review